{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T10:52:41Z","timestamp":1785149561223,"version":"3.55.0"},"reference-count":130,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000061","name":"Fogarty International Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000061","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Cardiovascular Diseases"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.pcad.2020.01.006","type":"journal-article","created":{"date-parts":[[2020,1,31]],"date-time":"2020-01-31T03:19:31Z","timestamp":1580440771000},"page":"160-169","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Prevention of stroke in people living with HIV"],"prefix":"10.1016","volume":"63","author":[{"given":"Ivy","family":"Nguyen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony S.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felicia C.","family":"Chow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.pcad.2020.01.006_bb0005","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1212\/WNL.0b013e31820a0cfc","article-title":"Increasing incidence of ischemic stroke in patients with HIV infection","volume":"76","author":"Ovbiagele","year":"2011","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.pcad.2020.01.006_bb0010","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1016\/j.jstrokecerebrovasdis.2018.02.016","article-title":"Stroke in HIV-infected individuals in sub-Saharan Africa (SSA): a systematic review","volume":"27","author":"Abdallah","year":"2018","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"2","key":"10.1016\/j.pcad.2020.01.006_bb0015","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1177\/2040622312471840","article-title":"HIV stroke risk: evidence and implications","volume":"4","author":"Singer","year":"2013","journal-title":"Therapeutic Advances in Chronic Disease"},{"issue":"11","key":"10.1016\/j.pcad.2020.01.006_bb0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0207005","article-title":"Global and regional trends of people living with HIV aged 50 and over: Estimates and projections for 2000\u20132020","volume":"13","author":"Autenrieth","year":"2018","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.pcad.2020.01.006_bb0025","first-page":"280","article-title":"Stroke in HIV","volume":"35","author":"Bogorodskaya","year":"2019","journal-title":"Can J Cardiol"},{"issue":"10","key":"10.1016\/j.pcad.2020.01.006_bb0030","doi-asserted-by":"crossref","first-page":"633","DOI":"10.4330\/wjc.v7.i10.633","article-title":"Cardiovascular disease in human immunodeficiency virus infected patients: a true or perceived risk?","volume":"7","author":"Shahbaz","year":"2015","journal-title":"World J Cardiol"},{"issue":"8","key":"10.1016\/j.pcad.2020.01.006_bb0035","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1093\/cid\/ciw470","article-title":"Trends in cardiovascular disease mortality among persons with HIV in New York City, 2001\u20132012","volume":"63","author":"Hanna","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.pcad.2020.01.006_bb0040","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1097\/QAI.0b013e3181e9be6b","article-title":"Serious fatal and nonfatal non-AIDS-defining illnesses in Europe","volume":"55","author":"Mocroft","year":"2010","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"13","key":"10.1016\/j.pcad.2020.01.006_bb0045","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1097\/QAD.0000000000000352","article-title":"HIV infection and incidence of ischemic stroke","volume":"28","author":"Marcus","year":"2014","journal-title":"AIDS"},{"issue":"13","key":"10.1016\/j.pcad.2020.01.006_bb0050","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1097\/QAD.0b013e3283493fb0","article-title":"Risk of cerebrovascular events in persons with and without HIV: a Danish nationwide population-based cohort study","volume":"25","author":"Rasmussen","year":"2011","journal-title":"AIDS"},{"issue":"14","key":"10.1016\/j.pcad.2020.01.006_bb0055","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.012241","article-title":"HIV infection and incidence of cardiovascular diseases: an analysis of a large healthcare database","volume":"8","author":"Alonso","year":"2019","journal-title":"JAHA"},{"issue":"4","key":"10.1016\/j.pcad.2020.01.006_bb0060","first-page":"351","article-title":"Comparison of ischemic stroke incidence in HIV-infected and non\u2013HIV-infected patients in a US health care system","volume":"60","author":"Chow","year":"2012","journal-title":"JAIDS"},{"issue":"5","key":"10.1016\/j.pcad.2020.01.006_bb0065","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1007\/s13365-016-0439-2","article-title":"Risk of intracerebral hemorrhage in HIV\/AIDS: a systematic review and meta-analysis","volume":"22","author":"Behrouz","year":"2016","journal-title":"J Neurovirol"},{"issue":"19","key":"10.1016\/j.pcad.2020.01.006_bb0070","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1212\/WNL.0000000000000958","article-title":"Elevated rates of intracerebral hemorrhage in individuals from a US clinical care HIV cohort","volume":"83","author":"Chow","year":"2014","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.pcad.2020.01.006_bb0075","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S1474-4422(19)30034-1","article-title":"Global, regional, and national burden of stroke, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"18","year":"2019","journal-title":"Lancet Neurol"},{"issue":"12","key":"10.1016\/j.pcad.2020.01.006_bb0080","doi-asserted-by":"crossref","first-page":"3564","DOI":"10.1161\/STROKEAHA.115.008226","article-title":"Global stroke belt: geographic variation in stroke burden worldwide","volume":"46","author":"Kim","year":"2015","journal-title":"Stroke"},{"issue":"2","key":"10.1016\/j.pcad.2020.01.006_bb0085","doi-asserted-by":"crossref","DOI":"10.4314\/thrb.v12i2.56397","article-title":"The prevalence of HIV among patients admitted with stroke at the Muhimbili National Hospital, Dar es Salaam, Tanzania","volume":"12","author":"Mlay","year":"2010","journal-title":"Tanzan J Health Res"},{"issue":"5","key":"10.1016\/j.pcad.2020.01.006_bb0090","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1093\/infdis\/jix340","article-title":"The role of human immunodeficiency virus-associated vasculopathy in the etiology of stroke","volume":"216","author":"Benjamin","year":"2017","journal-title":"J Infect Dis"},{"issue":"11","key":"10.1016\/j.pcad.2020.01.006_bb0095","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s11886-016-0794-x","article-title":"Cardiovascular complications of HIV in endemic countries","volume":"18","author":"Feinstein","year":"2016","journal-title":"Curr Cardiol Rep"},{"issue":"suppl 1","key":"10.1016\/j.pcad.2020.01.006_bb0100","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1097\/QAD.0000000000001888","article-title":"Noncommunicable diseases among HIV-infected persons in low-income and middle-income countries: a systematic review and meta-analysis","volume":"32","author":"Patel","year":"2018","journal-title":"AIDS"},{"issue":"6","key":"10.1016\/j.pcad.2020.01.006_bb0105","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1159\/000214219","article-title":"Cerebrovascular ischemic events in HIV-1-infected patients receiving highly active antiretroviral therapy: incidence and risk factors","volume":"27","author":"Corral","year":"2009","journal-title":"Cerebrovasc Dis"},{"issue":"7","key":"10.1016\/j.pcad.2020.01.006_bb0110","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1089\/aid.2012.0334","article-title":"Incidence and clinical features of cerebrovascular disease among HIV-infected adults in the Southeastern United States","volume":"29","author":"Vinikoor","year":"2013","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"5","key":"10.1016\/j.pcad.2020.01.006_bb0115","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.jstrokecerebrovasdis.2017.02.010","article-title":"Greater risk of stroke of undetermined etiology in a contemporary HIV-infected cohort compared with uninfected individuals","volume":"26","author":"Chow","year":"2017","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"7","key":"10.1016\/j.pcad.2020.01.006_bb0120","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1210\/jc.2006-2190","article-title":"Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease","volume":"92","author":"Triant","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.pcad.2020.01.006_bb0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0176686","article-title":"HIV infection as vascular risk: a systematic review of the literature and meta-analysis","volume":"12","author":"Gutierrez","year":"2017","journal-title":"PLoS One"},{"issue":"19","key":"10.1016\/j.pcad.2020.01.006_bb0130","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1212\/WNL.0000000000001560","article-title":"HIV status and the risk of ischemic stroke among men","volume":"84","author":"Sico","year":"2015","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.pcad.2020.01.006_bb0135","doi-asserted-by":"crossref","first-page":"335","DOI":"10.7326\/M14-0954","article-title":"Cigarette smoking prevalence among adults with HIV compared with the general adult population in the United States: cross-sectional surveys","volume":"162","author":"Mdodo","year":"2015","journal-title":"Ann Intern Med"},{"issue":"11","key":"10.1016\/j.pcad.2020.01.006_bb0140","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1093\/cid\/cix1075","article-title":"Silent cerebral small-vessel disease is twice as prevalent in middle-aged individuals with well-controlled, combination antiretroviral therapy-treated human immunodeficiency virus (HIV) than in HIV-uninfected individuals","volume":"66","author":"Moulignier","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.pcad.2020.01.006_bb0145","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1212\/WNL.0000000000002278","article-title":"HIV, antiretroviral treatment, hypertension, and stroke in Malawian adults: a case-control study","volume":"86","author":"Benjamin","year":"2016","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.pcad.2020.01.006_bb0150","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/OLQ.0000000000000250","article-title":"Sexually transmitted infection trends among gay or bisexual men from a clinic-based sentinel surveillance system in British Columbia, Canada","volume":"42","author":"Ling","year":"2015","journal-title":"Sex Transm Dis"},{"issue":"9S Suppl 1","key":"10.1016\/j.pcad.2020.01.006_bb0155","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1097\/OLQ.0000000000000870","article-title":"Historical and current trends in the epidemiology of early syphilis in San Francisco, 1955 to 2016","volume":"45","author":"Nguyen","year":"2018","journal-title":"Sex Transm Dis"},{"issue":"11","key":"10.1016\/j.pcad.2020.01.006_bb0160","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1093\/cid\/ciy348","article-title":"Risk factors and incidence of syphilis in human immunodeficiency virus (HIV)-infected persons: the HIV outpatient study, 1999\u20132015","volume":"67","author":"Novak","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.pcad.2020.01.006_bb0165","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1161\/01.STR.0000043821.35051.FA","article-title":"Stroke in black South African HIV-positive patients: a prospective analysis","volume":"34","author":"Mochan","year":"2003","journal-title":"Stroke"},{"issue":"1","key":"10.1016\/j.pcad.2020.01.006_bb0170","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1161\/str.23.1.117b","article-title":"Ischemic stroke as the sole manifestation of human immunodeficiency virus infection","volume":"23","author":"Casado Naranjo","year":"1992","journal-title":"Stroke"},{"issue":"5","key":"10.1016\/j.pcad.2020.01.006_bb0175","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/bjh.13783","article-title":"Haematological manifestations of human immune deficiency virus infection","volume":"171","author":"Vishnu","year":"2015","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.pcad.2020.01.006_bb0180","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/COH.0000000000000019","article-title":"Markers of coagulation and inflammation often remain elevated in ART-treated HIV-infected patients","volume":"9","author":"Funderburg","year":"2014","journal-title":"Curr Opin HIV AIDS"},{"issue":"16","key":"10.1016\/j.pcad.2020.01.006_bb0185","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1212\/01.wnl.0000259515.45579.1e","article-title":"Mechanisms of ischemic stroke in HIV-infected patients","volume":"68","author":"Ortiz","year":"2007","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.pcad.2020.01.006_bb0190","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1136\/jnnp.2004.059733","article-title":"Protein S deficiency in HIV associated ischaemic stroke: an epiphenomenon of HIV infection","volume":"76","author":"Mochan","year":"2005","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"10","key":"10.1016\/j.pcad.2020.01.006_bb0195","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1136\/jnnp.2005.072017","article-title":"HIV infection and stroke: if not protein S deficiency then what explains the relationship?","volume":"76","author":"Qureshi","year":"2005","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"10.1016\/j.pcad.2020.01.006_bb0200","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1093\/cid\/civ325","article-title":"HIV Infection is associated with progression of subclinical carotid atherosclerosis","volume":"61","author":"Hanna","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"13","key":"10.1016\/j.pcad.2020.01.006_bb0205","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1161\/01.CIR.0000124480.32233.8A","article-title":"Progression of atherosclerosis as assessed by carotid intima-media thickness in patients with HIV infection","volume":"109","author":"Hsue","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2020.01.006_bb0210","first-page":"235","article-title":"The effect of HIV infection, antiretroviral therapy on carotid intima-media thickness: a systematic review and meta-analysis","volume":"116851","author":"Msoka","year":"2019","journal-title":"Life Sci"},{"issue":"8","key":"10.1016\/j.pcad.2020.01.006_bb0215","doi-asserted-by":"crossref","first-page":"695","DOI":"10.3851\/IMP3258","article-title":"Carotid magnetic resonance imaging in persons living with HIV and 10-year atherosclerotic cardiovascular disease risk score","volume":"23","author":"Mee","year":"2018","journal-title":"Antivir Ther (Lond)"},{"issue":"2","key":"10.1016\/j.pcad.2020.01.006_bb0220","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/QAI.0B013E31822D4993","article-title":"HIV infection and progression of carotid and coronary atherosclerosis: the CARE study","volume":"58","author":"Mangili","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"3","key":"10.1016\/j.pcad.2020.01.006_bb0225","first-page":"415","article-title":"Brain large artery inflammation associated with HIV and large artery remodeling","volume":"30","author":"Gutierrez","year":"2016","journal-title":"AIDS"},{"issue":"8","key":"10.1016\/j.pcad.2020.01.006_bb0230","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1056\/NEJMoa022048","article-title":"Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection","volume":"348","author":"Bozzette","year":"2003","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.pcad.2020.01.006_bb0235","doi-asserted-by":"crossref","first-page":"e291","DOI":"10.1016\/S2352-3018(18)30043-2","article-title":"Cardiovascular disease and use of contemporary protease inhibitors: the D:A:D international prospective multicohort study","volume":"5","author":"Ryom","year":"2018","journal-title":"Lancet HIV"},{"issue":"5","key":"10.1016\/j.pcad.2020.01.006_bb0240","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1177\/0003319718801093","article-title":"Prevalence, incidence, and contributors of subclinical atheromatosis, arteriosclerosis, and arterial hypertrophy in HIV-infected individuals: a single-center, 3-year prospective study","volume":"70","author":"Psichogiou","year":"2019","journal-title":"Angiology"},{"issue":"4","key":"10.1016\/j.pcad.2020.01.006_bb0245","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/QAI.0b013e31826f993c","article-title":"No association of abacavir use with myocardial infarction: findings of an FDA meta-analysis","volume":"61","author":"Ding","year":"2012","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"3","key":"10.1016\/j.pcad.2020.01.006_bb0250","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0059551","article-title":"Risk of cardiovascular disease from antiretroviral therapy for HIV: a systematic review. Landay A, ed","volume":"8","author":"Bavinger","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.pcad.2020.01.006_bb0255","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1093\/cid\/cir269","article-title":"Abacavir use and risk of acute myocardial infarction and cerebrovascular events in the highly active antiretroviral therapy era","volume":"53","author":"Bedimo","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.pcad.2020.01.006_bb0260","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s13365-010-0006-1","article-title":"HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors","volume":"17","author":"Heaton","year":"2011","journal-title":"J Neurovirol"},{"issue":"23","key":"10.1016\/j.pcad.2020.01.006_bb0265","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1212\/WNL.0b013e318200d727","article-title":"HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study","volume":"75","author":"Heaton","year":"2010","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.pcad.2020.01.006_bb0270","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1080\/13550280490521078","article-title":"Prevalence and pattern of neuropsychological impairment in human immunodeficiency virus-infected\/acquired immunodeficiency syndrome (HIV\/AIDS) patients across pre- and post-highly active antiretroviral therapy eras: a combined study of two cohorts","volume":"10","author":"Cysique","year":"2004","journal-title":"J Neurovirol"},{"issue":"10","key":"10.1016\/j.pcad.2020.01.006_bb0275","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1212\/WNL.0b013e3181f11bd8","article-title":"Cardiovascular risk factors associated with lower baseline cognitive performance in HIV-positive persons","volume":"75","author":"Wright","year":"2010","journal-title":"Neurology"},{"issue":"16","key":"10.1016\/j.pcad.2020.01.006_bb0280","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1212\/WNL.0b013e3181bd10e7","article-title":"Vascular risk factors, HIV serostatus, and cognitive dysfunction in gay and bisexual men","volume":"73","author":"Becker","year":"2009","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.pcad.2020.01.006_bb0285","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/01.qai.0000243119.67529.f5","article-title":"Insulin resistance is associated with cognition among HIV-1-infected patients: the Hawaii Aging With HIV cohort","volume":"43","author":"Valcour","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"3","key":"10.1016\/j.pcad.2020.01.006_bb0290","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/QAI.0000000000000458","article-title":"Abdominal obesity contributes to neurocognitive impairment in HIV infected patients with increased inflammation and immune activation","volume":"68","author":"Sattler","year":"2015","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"7","key":"10.1016\/j.pcad.2020.01.006_bb0295","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1097\/QAD.0000000000001017","article-title":"Determinants of reduced cognitive performance in HIV-1-infected middle-aged men on combination antiretroviral therapy","volume":"30","author":"Schouten","year":"2016","journal-title":"AIDS"},{"issue":"4","key":"10.1016\/j.pcad.2020.01.006_bb0300","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s13365-015-0330-6","article-title":"Human immunodeficiency virus (HIV) modulates the associations between insulin resistance and cognition in the current combination antiretroviral therapy (cART) era: a study of the Women\u2019s Interagency HIV Study (WIHS)","volume":"21","author":"Valcour","year":"2015","journal-title":"J Neurovirol"},{"issue":"7","key":"10.1016\/j.pcad.2020.01.006_bb0305","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1212\/WNL.0b013e3182478d64","article-title":"Role of obesity, metabolic variables, and diabetes in HIV-associated neurocognitive disorder","volume":"78","author":"McCutchan","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.pcad.2020.01.006_bb0310","doi-asserted-by":"crossref","unstructured":"Wallin A, Rom\u00e1n GC, Esiri M, et al. Update on vascular cognitive impairment associated with subcortical small-vessel disease2. J Alzheimers Dis. 62(3):1417\u20131441. doi:https:\/\/doi.org\/10.3233\/JAD-170803","DOI":"10.3233\/JAD-170803"},{"issue":"3","key":"10.1016\/j.pcad.2020.01.006_bb0315","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1007\/s13365-016-0509-5","article-title":"White matter hyperintensities correlate to cognition and fiber tract integrity in older adults with HIV","volume":"23","author":"Watson","year":"2017","journal-title":"J Neurovirol"},{"issue":"15","key":"10.1016\/j.pcad.2020.01.006_bb0320","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1097\/QAD.0000000000001133","article-title":"White matter hyperintensities in relation to cognition in HIV-infected men with sustained suppressed viral load on combination antiretroviral therapy","volume":"30","author":"Su","year":"2016","journal-title":"AIDS"},{"issue":"21","key":"10.1016\/j.pcad.2020.01.006_bb0325","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1161\/CIRCULATIONAHA.117.028975","article-title":"Cardiovascular risk prediction functions underestimate risk in HIV infection","volume":"137","author":"Triant","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2020.01.006_bb0330","unstructured":"Comparing Cardiovascular Disease Risk Scores for Use in HIV-Infected Individuals | CROI Conference. http:\/\/www.croiconference.org\/sessions\/comparing-cardiovascular-disease-risk-scores-use-hiv-infected-individuals. Accessed October 7, 2019."},{"issue":"5","key":"10.1016\/j.pcad.2020.01.006_bb0335","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1097\/HJR.0b013e328336a150","article-title":"Predicting the risk of cardiovascular disease in HIV-infected patients: the data collection on adverse effects of anti-HIV drugs study","volume":"17","author":"Friis-M\u00f8ller","year":"2010","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"issue":"2","key":"10.1016\/j.pcad.2020.01.006_bb0340","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1177\/2047487315579291","article-title":"An updated prediction model of the global risk of cardiovascular disease in HIV-positive persons: the Data-collection on Adverse Effects of Anti-HIV Drugs (D:A:D) study","volume":"23","author":"Friis-M\u00f8ller","year":"2016","journal-title":"Eur J Prev Cardiol"},{"issue":"24","key":"10.1016\/j.pcad.2020.01.006_bb0345","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1212\/01.wnl.0000437296.97946.73","article-title":"Long-term predictive value of the Framingham Risk Score for Stroke in HIV-positive vs HIV-negative men","volume":"81","author":"Mateen","year":"2013","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.pcad.2020.01.006_bb0350","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1001\/jamacardio.2016.4494","article-title":"Assessing and refining myocardial infarction risk estimation among patients with human immunodeficiency virus: a study by the centers for AIDS research network of integrated clinical systems","volume":"2","author":"Feinstein","year":"2017","journal-title":"JAMA Cardiol"},{"issue":"4","key":"10.1016\/j.pcad.2020.01.006_bb0355","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1086\/314660","article-title":"Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage","volume":"179","author":"Giorgi","year":"1999","journal-title":"J Infect Dis"},{"issue":"22","key":"10.1016\/j.pcad.2020.01.006_bb0360","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1056\/NEJMoa062360","article-title":"CD4+ count-guided interruption of antiretroviral treatment","volume":"355","author":"Strategies for Management of Antiretroviral Therapy (SMART) Study Group","year":"2006","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.pcad.2020.01.006_bb0365","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1089\/aid.2014.0069","article-title":"Taming HIV-related inflammation with physical activity: a matter of timing","volume":"30","author":"d\u2019Ettorre","year":"2014","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"11","key":"10.1016\/j.pcad.2020.01.006_bb0370","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1080\/09540121.2014.920075","article-title":"Associations between physical activity and sedentary time on components of metabolic syndrome among adults with HIV","volume":"26","author":"Jaggers","year":"2014","journal-title":"AIDS Care"},{"issue":"2","key":"10.1016\/j.pcad.2020.01.006_bb0375","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s12160-013-9489-3","article-title":"Physical activity and health outcomes among HIV-infected men who have sex with men: a longitudinal mediational analysis","volume":"46","author":"Blashill","year":"2013","journal-title":"Ann Behav Med"},{"issue":"25","key":"10.1016\/j.pcad.2020.01.006_bb0380","first-page":"e1082","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"139","author":"Grundy Scott","year":"2019","journal-title":"Circulation"},{"issue":"30","key":"10.1016\/j.pcad.2020.01.006_bb0385","doi-asserted-by":"crossref","first-page":"4638","DOI":"10.2174\/1381612822666160510125229","article-title":"Statins in stroke prevention: present and future","volume":"22","author":"Castilla-Guerra","year":"2016","journal-title":"Curr Pharm Des"},{"issue":"2","key":"10.1016\/j.pcad.2020.01.006_bb0390","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.ijcard.2011.10.128","article-title":"Impact of statin dose on major cardiovascular events: a mixed treatment comparison meta-analysis involving more than 175,000 patients","volume":"166","author":"Ribeiro","year":"2013","journal-title":"Int J Cardiol"},{"issue":"12","key":"10.1016\/j.pcad.2020.01.006_bb0395","doi-asserted-by":"crossref","first-page":"3754","DOI":"10.1161\/STR.0000000000000046","article-title":"Guidelines for the primary prevention of stroke","volume":"45","author":"Meschia James","year":"2014","journal-title":"Stroke"},{"issue":"7","key":"10.1016\/j.pcad.2020.01.006_bb0400","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1161\/STR.0000000000000024","article-title":"Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"45","author":"Kernan","year":"2014","journal-title":"Stroke"},{"issue":"6","key":"10.1016\/j.pcad.2020.01.006_bb0405","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1056\/NEJMoa061894","article-title":"High-dose atorvastatin after stroke or transient ischemic attack","volume":"355","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2020.01.006_bb0410","series-title":"2019 ACC\/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"51","year":"2019"},{"issue":"12","key":"10.1016\/j.pcad.2020.01.006_bb0415","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1016\/j.amjcard.2015.03.025","article-title":"A systematic review of the usefulness of statin therapy in HIV-infected patients","volume":"115","author":"Feinstein","year":"2015","journal-title":"Am J Cardiol"},{"issue":"6","key":"10.1016\/j.pcad.2020.01.006_bb0420","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1177\/0956462415585448","article-title":"Use of aspirin and statins for the primary prevention of myocardial infarction and stroke in patients with human immunodeficiency virus infection","volume":"27","author":"Park","year":"2016","journal-title":"Int J STD AIDS"},{"issue":"4","key":"10.1016\/j.pcad.2020.01.006_bb0425","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1097\/QAI.0000000000000478","article-title":"Rosuvastatin reduces vascular inflammation and T-cell and monocyte activation in HIV-infected subjects on antiretroviral therapy","volume":"68","author":"Funderburg","year":"2015","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"4","key":"10.1016\/j.pcad.2020.01.006_bb0430","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1093\/cid\/cit748","article-title":"Rosuvastatin treatment reduces markers of monocyte activation in HIV-infected subjects on antiretroviral therapy","volume":"58","author":"Funderburg","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.pcad.2020.01.006_bb0435","doi-asserted-by":"crossref","first-page":"e52","DOI":"10.1016\/S2352-3018(14)00032-0","article-title":"Effects of statin therapy on coronary artery plaque volume and high-risk plaque morphology in HIV-infected patients with subclinical atherosclerosis: a randomised, double-blind, placebo-controlled trial","volume":"2","author":"Lo","year":"2015","journal-title":"Lancet HIV"},{"issue":"8","key":"10.1016\/j.pcad.2020.01.006_bb0440","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1093\/infdis\/jiu012","article-title":"Effect of 24 weeks of statin therapy on systemic and vascular inflammation in HIV-infected subjects receiving antiretroviral therapy","volume":"209","author":"Eckard","year":"2014","journal-title":"J Infect Dis"},{"issue":"14","key":"10.1016\/j.pcad.2020.01.006_bb0445","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1097\/QAD.0000000000001167","article-title":"Rosuvastatin slows progression of subclinical atherosclerosis in patients with treated HIV infection","volume":"30","author":"Longenecker","year":"2016","journal-title":"AIDS"},{"issue":"12","key":"10.1016\/j.pcad.2020.01.006_bb0450","doi-asserted-by":"crossref","first-page":"3445","DOI":"10.1128\/AAC.45.12.3445-3450.2001","article-title":"Pharmacokinetic interactions between nelfinavir and 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors atorvastatin and simvastatin","volume":"45","author":"Hsyu","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1016\/j.pcad.2020.01.006_bb0455","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s40256-017-0222-7","article-title":"Recommendations for managing drug-drug interactions with statins and HIV medications","volume":"17","author":"Wiggins","year":"2017","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1016\/j.pcad.2020.01.006_bb0460","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ahj.2018.12.016","article-title":"Rationale and design of the randomized trial to prevent vascular events in HIV (REPRIEVE)","volume":"212","author":"Grinspoon","year":"2019","journal-title":"Am Heart J"},{"key":"10.1016\/j.pcad.2020.01.006_bb0465","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ahj.2019.02.011","article-title":"Rationale and design of the mechanistic substudy of the randomized trial to prevent vascular events in HIV (REPRIEVE): effects of pitavastatin on coronary artery disease and inflammatory biomarkers","volume":"212","author":"Hoffmann","year":"2019","journal-title":"Am Heart J"},{"issue":"16","key":"10.1016\/j.pcad.2020.01.006_bb0470","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1056\/NEJMoa1804988","article-title":"Effects of aspirin for primary prevention in persons with diabetes mellitus","volume":"379","author":"Bowman","year":"2018","journal-title":"N Engl J Med"},{"issue":"16","key":"10.1016\/j.pcad.2020.01.006_bb0475","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1056\/NEJMoa1803955","article-title":"Effect of aspirin on all-cause mortality in the healthy elderly","volume":"379","author":"McNeil","year":"2018","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.pcad.2020.01.006_bb0480","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1016\/j.amjcard.2011.02.325","article-title":"Meta-analysis of multiple primary prevention trials of cardiovascular events using aspirin","volume":"107","author":"Bartolucci","year":"2011","journal-title":"Am J Cardiol"},{"issue":"7","key":"10.1016\/j.pcad.2020.01.006_bb0485","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.amjmed.2011.01.018","article-title":"Effect of aspirin on mortality in the primary prevention of cardiovascular disease","volume":"124","author":"Raju","year":"2011","journal-title":"Am J Med"},{"issue":"13","key":"10.1016\/j.pcad.2020.01.006_bb0490","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1056\/NEJMoa050613","article-title":"A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women","volume":"352","author":"Ridker","year":"2005","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.pcad.2020.01.006_bb0495","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1001\/archinte.159.11.1248","article-title":"A metaregression analysis of the dose-response effect of aspirin on stroke","volume":"159","author":"Johnson","year":"1999","journal-title":"Arch Intern Med"},{"issue":"1","key":"10.1016\/j.pcad.2020.01.006_bb0500","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1215340","article-title":"Clopidogrel with aspirin in acute minor stroke or transient ischemic attack","volume":"369","author":"Wang","year":"2013","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.pcad.2020.01.006_bb0505","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1056\/NEJMoa1800410","article-title":"Clopidogrel and aspirin in acute ischemic stroke and high-risk TIA","volume":"379","author":"Johnston","year":"2018","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.pcad.2020.01.006_bb0510","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1105335","article-title":"Stenting versus aggressive medical therapy for intracranial arterial stenosis","volume":"365","author":"Chimowitz","year":"2011","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.pcad.2020.01.006_bb0515","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1093\/cid\/cis752","article-title":"Underutilization of aspirin for primary prevention of cardiovascular disease among HIV-infected patients","volume":"55","author":"Burkholder","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.pcad.2020.01.006_bb0520","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1097\/QAI.0b013e3181d913fd","article-title":"Aspirin is indicated for primary prevention of cardiovascular events in HIV-infected patients","volume":"54","author":"Tornero","year":"2010","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"3","key":"10.1016\/j.pcad.2020.01.006_bb0525","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofu076","article-title":"Aspirin use for primary and secondary prevention in human immunodeficiency virus (HIV)-infected and HIV-uninfected patients","volume":"1","author":"Suchindran","year":"2014","journal-title":"Open Forum Infect Dis"},{"issue":"5","key":"10.1016\/j.pcad.2020.01.006_bb0530","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s15010-016-0893-z","article-title":"Statins and aspirin use in HIV-infected people: gap between European AIDS Clinical Society guidelines and clinical practice: the results from HIV-HY study","volume":"44","author":"De Socio","year":"2016","journal-title":"Infection"},{"key":"10.1016\/j.pcad.2020.01.006_bb0535","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ijcard.2018.04.052","article-title":"Effect of aspirin treatment on abacavir-associated platelet hyperreactivity in HIV-infected patients","volume":"263","author":"Falcinelli","year":"2018","journal-title":"Int J Cardiol"},{"issue":"1","key":"10.1016\/j.pcad.2020.01.006_bb0540","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/QAD.0000000000001666","article-title":"Abacavir use and risk of recurrent myocardial infarction","volume":"32","author":"Sabin","year":"2018","journal-title":"AIDS"},{"issue":"3","key":"10.1016\/j.pcad.2020.01.006_bb0545","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/QAI.0b013e31828a292c","article-title":"Aspirin attenuates platelet activation and immune activation in HIV-1-infected subjects on antiretroviral therapy: a pilot study","volume":"63","author":"O\u2019Brien","year":"2013","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"10.1016\/j.pcad.2020.01.006_bb0550","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofw278","article-title":"A randomized placebo controlled trial of aspirin effects on immune activation in chronically human immunodeficiency virus-infected adults on virologically suppressive antiretroviral therapy","volume":"4","author":"O\u2019Brien","year":"2017","journal-title":"Open Forum Infect Dis"},{"issue":"5","key":"10.1016\/j.pcad.2020.01.006_bb0555","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1177\/1358863X18789783","article-title":"Association of HIV infection with age and symptomatic carotid atherosclerotic disease at the time of carotid intervention in the United States","volume":"23","author":"Lin","year":"2018","journal-title":"Vasc Med"},{"issue":"3","key":"10.1016\/j.pcad.2020.01.006_bb0560","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0194754","article-title":"Atrial arrhythmia prevalence and characteristics for human immunodeficiency virus-infected persons and matched uninfected controls","volume":"13","author":"Sanders","year":"2018","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.pcad.2020.01.006_bb0565","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/QAI.0000000000001470","article-title":"CHA2DS2-VASc score, warfarin use, and risk for thromboembolic events among HIV-infected persons with atrial fibrillation","volume":"76","author":"Chau","year":"2017","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"6","key":"10.1016\/j.pcad.2020.01.006_bb0570","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1097\/COH.0000000000000412","article-title":"Use of direct oral anticoagulants for treatment of atrial fibrillation in patients with HIV: a review","volume":"12","author":"West","year":"2017","journal-title":"Curr Opin HIV AIDS"},{"key":"10.1016\/j.pcad.2020.01.006_bb0575","series-title":"Handbook of Clinical Neurology","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/B978-0-444-63849-6.00015-3","article-title":"HIV infection and stroke","volume":"152","author":"Benjamin","year":"2018"},{"key":"10.1016\/j.pcad.2020.01.006_bb0580","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2015-211651","article-title":"Novel oral anticoagulants and HIV: dabigatran use with antiretrovirals","volume":"2015","author":"Perram","year":"2015","journal-title":"BMJ Case Rep"},{"issue":"4","key":"10.1016\/j.pcad.2020.01.006_bb0585","first-page":"836","article-title":"Successful co-administration of dabigatran etexilate and protease inhibitors ritonavir\/lopinavir in a patient with atrial fibrillation","volume":"112","author":"Barco","year":"2014","journal-title":"Thromb Haemost"},{"issue":"6","key":"10.1016\/j.pcad.2020.01.006_bb0590","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1177\/1060028014523115","article-title":"Drug interactions between antiplatelet or novel oral anticoagulant medications and antiretroviral medications","volume":"48","author":"Egan","year":"2014","journal-title":"Ann Pharmacother"},{"issue":"4","key":"10.1016\/j.pcad.2020.01.006_bb0595","first-page":"146","article-title":"HIV-related cardiovascular disease, statins, and the REPRIEVE trial","volume":"23","author":"Gilbert","year":"2015","journal-title":"Top Antivir Med"},{"issue":"25","key":"10.1016\/j.pcad.2020.01.006_bb0600","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1056\/NEJMoa1410489","article-title":"Ezetimibe added to statin therapy after acute coronary syndromes","volume":"372","author":"Cannon","year":"2015","journal-title":"N Engl J Med"},{"issue":"18","key":"10.1016\/j.pcad.2020.01.006_bb0605","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","article-title":"Evolocumab and clinical outcomes in patients with cardiovascular disease","volume":"376","author":"Sabatine","year":"2017","journal-title":"N Engl J Med"},{"issue":"9493","key":"10.1016\/j.pcad.2020.01.006_bb0610","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0140-6736(05)67394-1","article-title":"Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins","volume":"366","author":"Baigent","year":"2005","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.pcad.2020.01.006_bb0615","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.002683","article-title":"HIV and hepatitis C-coinfected patients have lower low-density lipoprotein cholesterol despite higher proprotein convertase subtilisin kexin 9 (PCSK9): an apparent \u201cPCSK9-lipid paradox\u201d","volume":"5","author":"Kohli","year":"2016","journal-title":"J Am Heart Assoc"},{"issue":"17","key":"10.1016\/j.pcad.2020.01.006_bb0620","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1097\/QAD.0000000000001633","article-title":"Impact of protease inhibitors on circulating PCSK9 levels in HIV-infected antiretroviral-naive patients from an ongoing prospective cohort","volume":"31","author":"Boccara","year":"2017","journal-title":"AIDS"},{"key":"10.1016\/j.pcad.2020.01.006_bb0625","unstructured":"Effect of PCSK9 Inhibition on Cardiovascular Risk in Treated HIV Infection (EPIC-HIV Study) - Full Text View - ClinicalTrials.gov. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03207945. Accessed October 25, 2019."},{"issue":"12","key":"10.1016\/j.pcad.2020.01.006_bb0630","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1086\/652749","article-title":"Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection","volume":"201","author":"Neuhaus","year":"2010","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.pcad.2020.01.006_bb0635","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofx262","article-title":"Systemic inflammation, coagulation, and clinical risk in the START trial","volume":"4","author":"Baker","year":"2017","journal-title":"Open Forum Infect Dis"},{"issue":"9","key":"10.1016\/j.pcad.2020.01.006_bb0640","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0044454","article-title":"Inflammation, coagulation and cardiovascular disease in HIV-infected individuals","volume":"7","author":"Duprez","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.pcad.2020.01.006_bb0645","unstructured":"IL-1\u03b2 INHIBITION SIGNIFICANTLY REDUCES ATHEROSCLEROTIC INFLAMMATION IN TREATED HIV | CROI Conference. http:\/\/www.croiconference.org\/sessions\/il-1%CE%B2-inhibition-significantly-reduces-atherosclerotic-inflammation-treated-hiv. Accessed November 25, 2019."},{"issue":"11","key":"10.1016\/j.pcad.2020.01.006_bb0650","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1093\/cid\/ciy781","article-title":"Safety and impact of low-dose methotrexate on endothelial function and inflammation in individuals with treated human immunodeficiency virus: AIDS Clinical Trials Group Study A5314","volume":"68","author":"Hsue","year":"2019","journal-title":"Clin Infect Dis"}],"container-title":["Progress in Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033062020300281?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033062020300281?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T00:16:59Z","timestamp":1758500219000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0033062020300281"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":130,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S0033062020300281"],"URL":"https:\/\/doi.org\/10.1016\/j.pcad.2020.01.006","relation":{},"ISSN":["0033-0620"],"issn-type":[{"value":"0033-0620","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevention of stroke in people living with HIV","name":"articletitle","label":"Article Title"},{"value":"Progress in Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pcad.2020.01.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}